Home/Publication/Eight Roads Leads in Targeted Cancer Treatment
Eight Roads Leads in Targeted Cancer Treatment 

19 Oct 2023

US$ 19.00

Eight Roads Ventures (Eight Roads) was one of the investors that led the seed funding round of AlphaGen Therapeutics...

Price / article: US$19.00
OR existing subscriber
Related Publications

A consortium which consists of Abu Dhabi Investment Authority (ADIA), Global Infrastructure Partners, Khazanah Nasional...

KKR & Co Inc (KKR) announced its intention to launch its second tranche of tender offer (TOB) for shares of FUJI SOFT...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.